bluebird bio Inc (NAS:BLUE)
$ 0.9486 -0.0263 (-2.72%) Market Cap: 182.84 Mil Enterprise Value: 315.68 Mil PE Ratio: 0 PB Ratio: 0.45 GF Score: 37/100

bluebird bio Inc at Jefferies Healthcare Conference Transcript

Jun 04, 2019 / 03:30PM GMT
Release Date Price: $83.79 (+5.73%)
Biren N. Amin
Jefferies LLC, Research Division - MD and Senior Equity Research Analyst

Okay. Great. My name is Biren Amin. I would like to introduce our next company. We have bluebird bio and Chip Baird to give us some overview, their CFO.

Chip?

William D. Baird
bluebird bio, Inc. - CFO

Okay. Thanks, Biren. And I would like to thank the Jefferies team for inviting us to be here today. We're really excited to have the opportunity to tell you a little more about bluebird bio. I will be looking -- I will be making forward-looking statements, so I'll refer you to our safe harbor provision.

And at bluebird, we recode for life. What do we mean by that? So if you were to travel to our headquarters in Cambridge, Massachusetts, you'll hear us talking a lot of about this concept of recoding, of fundamentally changing the science, of changing disease states, of changing how these medicines are manufactured and delivered, changing the commercial model. It's innovation from virtually every angle of the business.

And ultimately, it's a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot